Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Design Therapeutics, Inc. (DSGN)
|
Add to portfolio |
|
|
|
| Price: |
$19.87
| | Metrics |
| OS: |
56.0
|
M
| |
|
|
| Market cap: |
$1.11
|
B
| |
|
|
|
Net cash:
|
$303
|
M
| |
$5.41
|
per share
|
|
EV:
|
$809
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($88.5)
|
M
| |
|
|
| EPS |
($1.05)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.2 | 1.7 |
| Revenue growth | | -100.0% | -86.3% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 2.7 |
| Gross profit | 0.0 | 0.0 | 0.2 | -1.1 |
| Gross margin | | | 100.0% | -65.8% |
| Research and development | 48.6 | 24.8 | 6.1 | |
| General and administrative | 19.0 | 11.1 | 2.5 | 1.1 |
| EBIT | -67.6 | -35.8 | -8.3 | -1.9 |
| EBIT margin | | | -3685.8% | -115.4% |
| Pre-tax income | -63.3 | -35.5 | -8.3 | -2.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -63.3 | -35.5 | -8.3 | -2.0 |
| Net margin | | | -3663.7% | -123.8% |
| |
| Diluted EPS | ($1.14) | ($0.77) | ($0.52) | ($0.13) |
| Shares outstanding (diluted) | 55.7 | 45.9 | 15.8 | 15.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|